- Filed
- Mar 3, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 21, 2025 | 47.87M sh |
| Short Term Investments | FY 2024 · Dec 31, 2023 | $580.63M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $235.04M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $384.41M |
| Current Assets | FY 2024 · Dec 31, 2023 | $1.82B |
| Total Assets | FY 2024 · Dec 31, 2023 | $2.43B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 48.36M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $0 |
| Dividends Paid | FY 2024 · Dec 31, 2022 | $137.97M |
| Capex | FY 2024 · Dec 31, 2022 | $58.84M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $246.67M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $9.05 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $9.37 |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $281.6M |
| Net Income | FY 2024 · Dec 31, 2022 | $437.67M |
| Operating Income | FY 2024 · Dec 31, 2022 | $526.79M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $1.05B |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $745.6M |
| Revenue | FY 2024 · Dec 31, 2022 | $1.79B |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $1.24B |